CTOs on the Move

Versartis

www.versartis.com

 
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Todd Dekkinga
 Vice President of Information Technology Profile

Similar Companies

Prospero Health

At Prospero, we believe a person`s care should be determined by preference, not dictated by their medical condition. That`s why we are building a new kind of healthcare company, providing loving care and support for a growing population of people and their families facing serious illness. The rising challenge for people and their families, the healthcare system, and our country is significant, and that`s why we must meet it head on by hiring the best people with a heart for service. At Prospero, we empower people to live their best lives now with loving and compassionate home-based care and support.

Zoom Health Inc

Zoom Health Inc is a Orange, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

Infusion Systems

Infusion Systems is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Innovation Place

Innovation Place is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.